| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |